BioAge Labs, Inc. ($BIOA)
Filing Information
| Accession Number | 0001210905-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 3, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
26,460
Total Value
$201,656.58
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 5,437 | $4.11 | $22,346.07 | 5,437 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 3,383 | $6.57 | $22,226.31 | 8,820 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Sale | 8,820 | $17.81 | $157,084.20 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 5,437 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 3,383 | $0.00 | $0.00 | 0 | Direct | โ | View Details |